CCHT is committed t術志o growing into an open and
professional inter報鐵national enterprise.謝房

Changchun High-te弟房ch Industry (Group) Co., Ltd. wa月作s established by Changchun High-t著大ech Industry Devel見南opment Corporation in June 1993, wi白空th a total share capi北靜tal of 137,500,000 sh有朋ares.

On December 18,場女 1996, CCHT stocks were l城白isted at Shenzhen Stock Exch國睡ange. It is among the fi友答rst batch of listed companies i兒呢n northeast China.

Since its establis些務hment more than 20 years ago, 冷會CCHT successfully transform這地ed from high-tech area infrastructure坐金 construction into an enterprise group在什 focusing on the field of med喝飛ical science and technology innov劇來ation and implementing industrial i站時nvestment. CCHT has adhe書影red to the corporate culture of 站場‘‘innovation, concentratio那街n, generosity and shari唱為ng’’, practicing the c妹錢ore values of creatin城是g value for cust雨嗎omers, creating o生鐵pportunities for employees, creat睡錯ing benefits fo湖事r shareholders and taki視影ng responsibility for the society. I相務t has established its industr風吧ial orientation with biopharmaceutical票秒 industry as the primary and real estat劇醫e industry as the跳現 supplement, has formed 木機the development platf海北orm for three industries including 鐵北genetic engineering pharmaceuticals報好, biological va錢購ccines and modern trad愛藍itional Chinese me去睡dicine, has realize家醫d the vigorous developme銀姐nt pattern of ‘銀和‘four carriages’’ 科中including GeneScience Pharmaceut劇下icals Co., Ltd. (hereinafter re站藍ferred to as ‘‘Gen知錯Sci’’, Changchun BCHT好兒 Biotechnology Co., 刀自Ltd. (hereinafter referred to as 機就‘‘BCHT’’, Jilin Huakang Phar北低maceutical Co., Ltd. (hereinafter ref笑兒erred to as ‘‘Huakang Pharma道劇ceutical’’) and Changch服學un High-tech Real Es間市tate Development Co., Ltd. (here樹服inafter referred to as ‘‘Hig舊從h-tech Real Est做師ate’’ and has opened up a窗窗 good situation of sha音習red development and win-win co通錢operation. CCHT r看近anked 73rd and 56t風器h among the top 100 phar友謝maceutical industries in China in 2017 放問and 2018, respectively.